Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype

Medicine and Dentistry

• Cystic Fibrosis 100%
• Genotype 100%
• Cystic Fibrosis Transmembrane Conductance Regulator 100%
• Patient 100%
• Race 100%
• Hispanic 35%
• Ethnic Groups 21%
• Racial Group 14%
• Age 14%
• Diseases 7%
• Disparity 7%
• Patient with Cystic Fibrosis 7%
• Combination Therapy 7%
• Health Disparity 7%
• Disease Severity 7%
• Patient Registry 7%
• Mortality 7%
• Minority Group 7%
• Mutation Rate 7%
• Lung 7%
• Medication 7%
• Cross Sectional Study 7%
• Lung Function 7%

INIS

• patients 100%
• fibrosis 100%
• genotype 100%
• mutations 26%
• african americans 15%
• ethnic groups 15%
• diseases 10%
• racial groups 10%
• therapy 5%
• foundations 5%
• comparative evaluations 5%
• mortality 5%
• people 5%
• lungs 5%
• minority groups 5%
• us fda 5%
• mutation frequency 5%